0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
JAMA Patient Page |

Screening for Chronic Obstructive Pulmonary Disease FREE

Jill Jin, MD, MPH
JAMA. 2016;315(13):1419. doi:10.1001/jama.2016.3322.
Text Size: A A A
Published online

The US Preventive Services Task Force (USPSTF) has published updated recommendations on screening for chronic obstructive pulmonary disease (COPD).

WHAT IS CHRONIC OBSTRUCTIVE PULMONARY DISEASE?

Chronic obstructive pulmonary disease is a serious lung disease that affects the ability to breathe. In people with COPD, the airways inside the lungs are damaged and narrowed, causing problems with airflow in and out of the lungs. Common symptoms of COPD include shortness of breath, wheezing, and coughing. Two types of COPD are chronic bronchitis and emphysema. Asthma is another type of obstructive lung disease that has some overlap with COPD, but unlike asthma, lung changes that happen in COPD are not reversible. The most common cause of COPD is smoking, and the best way to prevent COPD in people who smoke is to stop smoking. The April 5, 2016, issue of JAMA contains the updated USPSTF recommendations about screening for COPD.

WHAT TESTS ARE USED TO SCREEN FOR COPD?

Screening for COPD can be done with a questionnaire about COPD risk factors, which, if it shows a high risk of COPD, is followed by diagnostic testing with spirometry. Spirometry tests for how well the lungs work by measuring how much air is inhaled and exhaled and how quickly it is exhaled, both before and after treatment with a type of inhaled medication called a bronchodilator. Another option is to do screening spirometry without a bronchodilator, followed by diagnostic spirometry if the screening test result is abnormal.

WHAT IS THE PATIENT POPULATION UNDER CONSIDERATION FOR SCREENING FOR COPD?

The USPSTF recommendation applies to adults who do not have any signs or symptoms of breathing problems. It does not apply to adults who may need preoperative testing for lung disease because they have a high risk of lung complications related to surgery.

WHAT ARE THE POTENTIAL BENEFITS AND HARMS OF SCREENING FOR COPD?

There are currently no studies on the benefits and harms of finding COPD in people who do not report symptoms of the disease. In people with known COPD, there is evidence that treatment with inhalers decreases COPD exacerbations (symptom flares). However, even in people with known COPD, studies have not shown consistent benefits of treatment on mortality or quality of life. Potential harms of treatment include side effects from using inhaled medications, although these are generally mild. Another factor is the time and cost of conducting both screening and diagnostic spirometry.

HOW STRONG IS THE RECOMMENDATION TO SCREEN FOR COPD?

Given the lack of evidence on the effects of screening in adults with no symptoms of COPD on health outcomes, the USPSTF has concluded that there is no net benefit to screening for COPD.

BOTTOM LINE: CURRENT RECOMMENDATION FOR SCREENING FOR COPD

The USPSTF concludes that screening for COPD is not recommended in adults who do not have symptoms suggestive of COPD (called a “D” statement).

Box Section Ref ID

For More Information

To find this and previous JAMA Patient Pages, go to the Patient Page link on JAMA’s website at www.jama.com. Spanish translations are available in the supplemental content tab. A Patient Page on diagnosis and treatment of COPD was published in the September 26, 2012, issue of JAMA.

ARTICLE INFORMATION

The JAMA Patient Page is a public service of JAMA. The information and recommendations appearing on this page are appropriate in most instances, but they are not a substitute for medical diagnosis. For specific information concerning your personal medical condition, JAMA suggests that you consult your physician. This page may be photocopied noncommercially by physicians and other health care professionals to share with patients. To purchase bulk reprints, call 312/464-0776.

Source: US Preventive Services Task Force. Screening for chronic obstructive pulmonary disease: US Preventive Services Task Force recommendation statement. JAMA. doi:10.1001/jama.2016.2638.

Topic: Preventive Medicine

Tables

References

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Spanish Patient Page: Prueba de detección de la enfermedad pulmonar obstructive crónica

Supplemental Content

Some tools below are only available to our subscribers or users with an online account.

3,983 Views
0 Citations
×

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Articles Related By Topic
Related Collections
PubMed Articles
Jobs
JAMAevidence.com

The Rational Clinical Examination: Evidence-Based Clinical Diagnosis
Airflow Limitation

The Rational Clinical Examination: Evidence-Based Clinical Diagnosis
Make the Diagnosis: Airflow Limitation